← Back to Search

Hyaluronic Acid Derivative

HYMOVIS for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Fidia Farmaceutici s.p.a.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Symptomatic osteoarthritis of the knee.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years

Summary

The purpose of this study is to determine whether intra-articular hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.

Eligible Conditions
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: HYMOVISExperimental Treatment1 Intervention
HYADD(TM) 4 Hydrogel Intra-Articular Injection
Group II: PlaceboPlacebo Group1 Intervention
Saline Intra-Articular Injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HYMOVIS
2015
N/A
~50

Find a Location

Who is running the clinical trial?

Fidia Farmaceutici s.p.a.Lead Sponsor
33 Previous Clinical Trials
4,510 Total Patients Enrolled
6 Trials studying Osteoarthritis
1,534 Patients Enrolled for Osteoarthritis
~29 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top